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Glossary of abbreviations 
C.O. 
bco, 
FRC 
vD 
A 
CaC0, 
CVCO, 
PGCO, 
PaC0, 
FI 
FE 
F~~~ 
- 
V 
cardiac output 
amount of C02 exhaled per minute which in steady 
state equal to the COq production rate 
functional residual capacity 
dead space 
alveolar 
arterial CO, content 
mixed venous CO, content 
arterial CO, partial pressure 
mixed venous CO, content 
refers to fractional concentration of inspired gas 
refers to fractional concentration of expired gas 
fractional concentration of a gas in the FRC 
-E1 subscript = end inspiratory 
-EE subscript = end expiratory 
mixed venous concentration 
D(c-A)COi pulmonary arterial (mixed venous)-alveolar COP 
concentration gradient 
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Introduction 
The purpose of this study was to develop a clinically practical 
techique to calculate mixed venous C02 partial pressure 
(P7CO2) for the calculation of cardiac output (C.O.) by the Fick 
technique. 
. 
The basis of using a Fick approach to measuring cardiac output 
has been extensively reviewed by Grollman (1). 
C02, the Fick principle states that the cardiac output is equal to 
the C02 production (VC02) divided by the arterio-venous 
C02 content difference of the pulmonary vessels 
(C3C02-CaC02). Stated in symbols, 
As it applies to 
. 
co = vco, 
L 
CX02-CaC02 
where CGC02 is the C02 content of blood in mixed venous blood 
entering the lungs and CaC02 is the C02 content of arterial 
blood. Of these, VC02 can be measured by analyzing a time 
collection of expired gas for C02. The CaC02 can be 
calculated from arterial partial pressure for C02 (PaC02). 
This in turn can be calculated noninvasively from end tidal gases 
(2) or relatively easily from an arterial puncture. It is the 
difficulties inherent in the noninvasive estimation of (PIC02) 
that have been the impediment to widespread application of the 
technique. 
A review of the principles involved in the various techniques 
used to estimate P?CO2 (for C+CO2 calculation) is presented by 
Richards and Strauss (3). They classify these techniques as attempts 
to "use the lungs as an aerotonometer, in an attempt to bring the lung 
gases into equilibrium with inflowing venous (pulmonary artery) blood 
before recirculation alters the character of this inflowing blood". 
These, as well as the more recent techniques depend on data gathered 
after certain subject manoeuvres. 
Breath holding techniques 
In one method as used by Dubois et at (4, 19) the subjects held 
their breath for variable periods of time then exhaled and a 
sample of end tidal gas was analyzed. The mixed venous PC02 
was derived from extrapolation of the end tidal PC02 values to 
an asymptote at infinite time or by calculating when the amount of 
C02 added to the lung was equal t o  0 (16). 
Frankel et a1 (5) had their subjects take a breath to vital 
capacity of gas containing either 100% O2 or 12X C02 in 
02. They held their breath and exhaled 500 ml at 5 seconds and 
then again at 15 sec. 
alveolar PC02 to PVC02, the PVC02 was calculated by 
extrapolating to the same PC02 value from above and below. 
Rebreathing techniques 
Defares (6) had subjects rebreath from a closed container and 
samples were analyzed after each exhalation. 
steadily in an exponential manner towards an asymptote (PSCO2) 
which was mathematically and graphically calculated. 
Assuming the exponential approach of 
The PC02 rose 
ii) Collier ( 7 ) ,  and later McEvoy et a1 (2) and Powles (8) 
described a technique where the subjects rebreathe from a bag 
containing an amount of C02 designed to allow the system to 
equilibrate at the mixed venous C02 tension. 
These techniques have been shown to predict mixed venous PC02 
extremely well in clinical situations such as patients under 
general anesthesia (9), or patients suffering from congestive heart 
failure (lo), severe respiratory disease (ll), with hypercapnea (12) 
and other severe diseases requiring intensive care (13, 14). Yet 
despite this and despite exhortations to be "less invasive" (15), 
none of these methods have been widely employed. 
The reasons for this are not difficult to discover. The above 
techniques have. 3 major drawbacks. 
They are cumbersome to perform. They require multiple pieces of 
equipment and critical manoeuvres. Often they require trial and 
error to find the proper conditions for a test. 
They require a patient manoeuvre. 
perform some manoeuvre or it must be performed on the patient. 
This may be technically difficult and aesthetically unpleasing to 
the physician. 
They require complex data analysis. Some techniques present 
difficulty in identifying data end points (8). Analysis of 
complex differential equations and polynomials is a difficult 
bedside procedure. 
This study was undertaken to a) develop another noninvasive 
method for predicting PVC02 that had the advantages of 
being easy to apply in a clinical setting 
allowing the patient t o  continue to breathe at his own 
frequency and tidal volume, requiring no rebreathing or 
brea tho lding 
having a simple linear mathematical approach. 
The patient must actively 
i) 
ii) 
iii) 
b) to show the feasibility of the method. 
A. 
R a t  i o n a l e  
STUDIES WITH N2 AS AN "INERT GAS" 
We assumed the lung t o  
a )  
. 
be a s i n g l e  compartment c o n t a i n e r  
b )  have ins t an taneous  mixing 
c) 
d )  
have a volume "FRC" ( f u n c t i o n a l  r e s i d u a l  c a p a c i t y )  
expand and c o n t r a c t  by  a c o n s t a n t  volume 
"VT" ( t i d a l  volume) 
Consider a s u b j e c t  brea th ing  spontaneous ly  a t  rest ,  e q u i l i b r a t e d  
t o  a gas  such as N2 which i s  no t  absorbed from, o r  does n o t  e l u t e  
i n t o ,  the lung. A f t e r  normal exha la t ion  t h e  s u b j e c t  i n h a l e s  a VT 
of gas  c o n t a i n i n g  a f r a c t i o n a l  concen t r a t ion  of  N2(FIN2) 
less than  t h e  prev ious  e q u i l i b r a t e d - t o  c o n c e n t r a t i o n .  When he 
e x h a l e s ,  the end t ida l  N2 fractional c o n c e n t r a t i o n  (FEN2) 
w i l l  be  less than  the e q u i l i b r a t e d  c o n c e n t r a t i o n  and g r e a t e r  than  t h e  
FIN2. 
least .  
the FEN2 w i l l  be equa l  t o  t h e  FIN2. 
To e x p l o r e  the r e l a t i o n s h i p  between FRC, VT, FIN2 and 
FEN2 w e  conducted the fol lowing experiment.  
I f  t h e  FIN2 i s  0 then t h e  FEN2 w i l l  be 
I f  the FIN2 i s  equa l  t o  t h e  e q u i l i b r a t e d  v a l u e  then 
*l 
EXPERIMENT 1: S i n z l e  b r e a t h  N2 t e s t i n %  - 
Method 
S i x  normal h e a l t h y  male volunteers '  were s t u d i e d .  S u b j e c t s  were 
a t  rest and were i n i t i a l l y  brea th ing  through a mouthpiece and a 
. 0 ~ ~ . ~ . ~ 0 . . . ~ . ~ 0 0 . 0 ~ ~ . . 0 0 0 ~ . 0 . . ~ ~ . . ~ . . . 0 . ~ ~ ~ . . ~ ~ ~ 0 . ~ . 0 0 ~ ~ 0 0 ~ ~ . . . . . ~ . ~ .  
l* We are ignor ing  the small f l u c t u a t i o n  i n  c o n c e t r a t i o n  caused b y  t h e  
d i sc repancy  i n  O2 abso rp t ion  and C02 product ion .  
c i r c u i t  dep ic t ed  i n  Fig. 1. 
a l lowing  i n h a l a t i o n  from one limb and e x h a l a t i o n  through another .  
i n h a l a t i o n a l  limb conta ined  a stopcock which a l lowed e i ther  room a i r  
o r  test  gas  t o  e n t e r  i t .  
o r i g i n a t i n g  c l o s e  t o  t h e  mouth. 
r o l l i n g  seal sp i rometer  connected t o  the e x p i r a t o r y  p a r t  of the 
c i r c u i t  . 
The c i r c u i t  had two one-way va lves  
"he 
Gas sampling w a s  done through a catheter 
Expi ra tory  volumes were measured by a 
Sub jec t s  brea thed  room a i r  through the c i r c u i t  u n t i l  they 
developed a r e g u l a r  p a t t e r n  of r e s p i r a t i o n .  
e x h a l a t i o n ,  the s topcock was turned so that  the n e x t  f o u r  b rea ths  
c o n s i s t e d  of t es t  gas .  
a i r .  
w i t h  another  tes t  gas.  
c o n c e n t r a t i o n s  between 2% and 60% were used f o r  each . . subjec t .  
A t  the end of an 
The subjec t  then  went back t o  b rea th ing  room 
A f t e r  a pe r iod  of a t  least 5 minutes the p rocess  was repea ted  
A t o t a l  of f o u r  test g a s e s  con ta in ing  N2 
Continuous gas  sampling was done by a Perking-Elmer MGA-1100 
Medical gas  ana lyze r  which was r e c a l i b r a t e d  w i t h  known gases  be fo re  
each s u b j e c t  w a s  t e s t ed .  
d i g i t a l i z e d  a t  a ra te  of 37 samples p e r  second and s t o r e d  on d i s k  by a 
Nors ta r  Horizon microcomputer. 
sampled gas .  
The volume and gas  a n a l y s i s  d a t a  was 
A l l  volumes were c o r r e c t e d  f o r  the 
The r e s u l t s  of t he  experiment are t a b u l a t e d  i n  Table  1. 
Figure  2 i s  a bar graph made from the d a t a  of H.S. 
the e f f e c t  of va r ious  F1N2's on the  FEN2. The minimum 
FEN2 occurs  a t  t h e  minimum FIN*. 
the d i f f e r e n c e  between i n s p i r e d  and exp i r ed  N2 concen t r a t ions  
b e a r s  a l inear  r e l a t i o n s h i p  t o  t h e  FIN2. 
It i l l u s t r a t e s  
Fig.  3 shows t h a t  
- a -  
Discuss ion  
The l i n e a r  r e l a t i o n s h i p  between FEN2 - FINz  and 
FINz  can  be expla ined  as follows. 
characteristics of the lung wi th  r e s p e c t  t o  N2 are  t h o s e  of a 
s i n g l e  chamber w i t h  ins tan taneous  mixing of  i n s p i r e d  gas (Fig.  4). 
breath i s  taken of a known Nz concen t r a t ion  of volume VT. The 
e x p i r e d  c o n c e n t r a t i o n  w i l l  be the t o t a l  amount o f  Nz i n  the lung 
divided by t h e  t o t a l  lung volume (16),(18). 
Again assume the mechanical. 
. - A 
- 
S t a t e d  i n  symbols: 
(1) <VT x FIN2) + FFRCNZ x FRC 
FEN2 = 
VT + FRC 
where FFRCN2 i s  t h e  N2 concen t r a t ion  i n  t h e  FRC.  
S u b t r a c t i n g  FIN2 from both  s i d e s ,  
FEN2 - FIN2 = (VT x FIN2) + (FFRCN2 x FRC) 
- FIN2 
VT + FRC 
FFRCN2 x FRC 
+ FRC -( vT ;FRc - 9 FIN2 + vT 
Equation 3 i s  i n  t h e  form y = mx + b, d e s c r i b i n g  t h e  l i n e a r  
r e l a t i o n s h i p  between FENZ - F I N 2  and FINZ. 
. 
The e x c e l l e n t  c o r r e l a t i o n  of these two variables i l l u s t r a t e d  
i n  Tab le  1 stems from t h e  cons t an t  VT for each  t es t  as measured 
and the presumed small variation i n  FRC a t  t h e  beginning of each test  
g a s  series. C l e a r l y ,  as t h e  VT is known and t h e  s l o p e  of t h e  l i n e  
- 9 -  
i s  known, t h e  FRC c a n  be c a l c u l a t e d  from t h e  s l o p e  o f  equat ion  3. 
This i s  t h e  s u b j e c t  of work i n  progress  a t  o u r  l a b o r a t o r y .  
We conclude t h a t  t h e  f i r s t  b r e a t h  of n i t r o g e n  i s  d i s t r i b u t e d  over  
a volume of the lung  which behaves as a s i n g l e  chamber wi th  
i n s t a t a n e o u s  mixing. It i s  t h i s  characterist ic which g i v e s  a l i n e a r  
r e l a t i o n s h i p  between FENZ and FINZ. 
I f  one had a s i t u a t i o n  where t h e  FFRC o f  gas was unknown (and 
r e c o n s t i t u t e d  between tests) one could  u s e  the approach o f  s t imulus  ( a  
b r e a t h  of d i f f e r e n t  concen t r a t ion  g a s )  and r e s p o n s e  (FE)  t o  
c a l c u l a t e  it. Any two p o i n t s  on an FE'FI vs FI graph  would 
d e f i n e  a l i n e  which c r o s s e s  t h e  a b s c i s s a  a t  FImFFRC, as can be 
seen  from equa t ion  3 b y  s e t t i n g  the  l e f t  hand s i d e  e q u a l  t o  0. 
- 10 - 
B. 
PC02 (P+CO2) NON INVASIVELY 
R a t i o n a l e  
STUDIES TO EXAMINE THE METHOD FOR DETEXMINING THE MIXED VENOUS 
To p r e d i c t  whether w e  could  expec t  a similar l i n e a r  r e l a t i o n s h i p  
between i n s p i r e d ,  e x p i r e d  and FRC c o n c e n t r a t i o n s  o f  C02,  w e  
cons ide red  t h e  e f f e c t  of d i l u t i o n  and d i f f u s i o n  on t h e  FEC02. 
I f  w e  imagine an  ins tan taneous  i n s p i r a t i o n  of V con ta in ing  T 
some C 0 2 ,  t h e  in s t an taneous  end i n s p i r a t o r y  FFRcCO~ 
should  bear a l i n e a r  r e l a t i o n s h i p  t o  t h e  FIC02 as was shown 
f o r  N2 i n  the previous  s e c t i o n ,  ignor ing  f o r  t h e  moment any 
C02  d i f f u s i o n  i n t o  the lung  from blood o r  t i s s u e  s t o r e s .  
Knowles e t  a1 (16), Dubois (19), Fenn and Dejours (18) showed 
tha t  t h e  change i n  C02 t e n s i o n  i n  the lung p e r  u n i t  t i m e  varies 
d i r e c t l y  as the C02 g r a d i e n t  between mixed venous blood and the 
a l v e o l i .  
c o n s t a n t .  
the lung t o  be d i r e c t l y  p r o p o r t i o n a l  t o  t h i s  C02  g r a d i e n t .  
I n  a r e g u l a r  p a t t e r n  of r e s p i r a t i o n  the d i f f u s i o n  t i m e  i s  
We can  expec t  t h e r e f o r e ,  t h e  change i n  C02 t ens ion  i n  
F ig .  5 r e p r e s e n t s  a schematic summary of the above events .  We 
assume the mixed venous blood has a p a r t i a l  p r e s s u r e  equ iva len t  t o  a 
C02  c o n c e n t r a t i o n  of an  arbitrary v a l u e  "8WI . 
(F1C02 = 0 ) ,  the end t i d a l  C02 concen t r a t ion  i s  d i l u t e d  t o  
"4'*. 
"4". 
Breath ing  room a i r  
This induces  a g r a d i e n t  from mixed venous blood t o  a l v e o l i  of 
I n  t h e  d u r a t i o n  of a b r e a t h ,  carbon d i o x i d e  d i f f u s e s  i n t o  the 
lung  i n  an  amount s u f f i c i e n t  t o  r e t u r n  t h e  c o n c e n t r a t i o n  back t o  "7". 
* I n  experiment 2 i n  Fig.  5 ,  we assume t h e  e v e n t s  t a k e  p l a c e  b e f o r e  
one r e c i r c u l a t i o n  t i m e  so that  t h e  e q u i v a l e n t  mixed venous C02 
c o n c e n t r a t i o n  stays c o n s t a n t  a t  "8". The s u b j e c t  begins  t o  b r e a t h e  a 
- 11 - 
gas  con ta in ing  a FIC02 g r e a t e r  than 0 b u t  less than  the mixed 
venous va lue .  A t  equi l ibr ium,  the  end i n s p i r a t o r y  d i l u t e d  
CO w i l l  be g r e a t e r  t han  the previous  v a l u e  (when F~~~ 2 
FIC02 was 0 ) .  
blood and a l v e o l i  i s  diminished compared t o  b r e a t h i n g  room a i r .  There 
w i l l  be a p ropor t iona te ly  smaller amount of  C02 d i f f u s i n g  i n t o  the 
a l v e o l i .  
than  the mixed venous va lue .  
4 each o f  which a l s o  r e p r e s e n t s  a s t e p  change f o r  a s u b j e c t  
e q u i l i b r a t e d  t o  room a i r .  
The g r a d i e n t  f o r  C 0 2  between mixed venous 
. 
The F ~ c 0 2  w i l l  be g r e a t e r  than  i n  exp t .  1 b u t  less 
Simi la r  even t s  occur  i n  experiment  3 and 
I n  exp t .  5 t h e  s u b j e c t  i n h a l e s  a c o n c e n t r a t i o n  of  C02  equa l  
t o  tha t  o f  h i s  mixed venous blood. Af t e r  one o r  more b r e a t h s  the 
C02  e n t e r i n g  the lungs  from the mixed venous blood and inha led  g a s  
b r i n g  the a l v e o l a r  concen t r a t ion  t o  t h e  mixed venous v a l u e  and there 
i s  no d i f f e r e n c e  between FIC02 and F ~ c 0 2  as long  as 
the t e s t  time i s  less than  a r e c i r c u l a t i o n  t i m e .  
Experiment 6 a l s o  r e p r e s e n t s  a c o n t i n u a t i o n  of  t h i s  argument f o r  
t h e  i n h a l a t i o n  of a g a s  whose FCOZ i s  g r e a t e r  t han  that  of  the 
mixed venous blood. The d i l u t i o n  argument h o l d s  unchanged. Knowles 
( 1 6 )  has a l s o  shown tha t  the amount of  C02 d i f f u s i n g  back i n t o  the 
lung p e r  u n i t  time cont inues  t o  be d i r e c t l y  p r o p o r t i o n a l  t o  the 
g r a d i e n t .  
I n  summary, w i th  r e s p e c t  t o  C02, the  FEC02 i s  
p r o p o r t i o n a l  t o  the amount of  C02 d i f f u s i n g  i n t o  the a l v e o l i  which 
i s  p r o p o r t i o n a l  t o  t h e  mixed venous - a l v e o l a r  C02  g r a d i e n t  which 
i t s e l f  i s  p r o p o r t i o n a l  t o  t h e  FIC02. 
expec t  a l i n e a r  r e l a t i o n s h i p  between FEC02 - FIC02 and FIC02 @is. 6). 
Therefore ,  w e  could 
- 12 - 
Experiment 2: 
Methods 
Thi rd  b r e a t h  C02 t e s t  -- 
S i x  normal male vo lun tee r s  were s tud ied .  Sub jec t s  were a t  res t  
and were b rea th ing  through a c i r c u i t  i d e n t i c a l  t o  one desc r ibed  f o r  
n i t r o g e n  t e s t i n g  (F ig .  1). 
O2 and N2 mix tures .  
The FI02 w a s  g r e a t e r  than  30%. 
The test gases  c o n s i s t e d  of C02 i n  . 
The FIC02 var ied  from 2% t o  8%. 
I n  the test  sequence the subjec t  was al lowed t o  b r e a t h e  through 
the c i r c u i t  u n t i l  a r e g u l a r  pa t t e rn  of r e s p i r a t i o n  had developed. 
the end of a normal exha la t ion  t h e  s topcock was turned  and t h e  s u b j e c t  
i nha led  f o u r  b r e a t h s  of a tes t  gas t r y i n g  n o t  t o  change the depth  and 
f requency  of h i s  b rea ths .  A t  the end of f o u r  breaths the s u b j e c t  was 
r e t u r n e d  t o  b r e a t h i n g  room a i r  for  a t  least  15 minutes  b e f o r e  another  
test gas  was appl ied .  
sub j ec t . 
A t  
A t o t a l  of f o u r  tests were performed on each 
I n s p i r e d  and exp i r ed  C02 was monitored con t inuous ly  by  a 
Perkins-Elmer MGA-1100 Medical gas analyzer .  The volumes were measured 
by a r o l l i n g  seal sp i rometer .  A l l  ins t ruments  were r e c a l i b r a t e d  
b e f o r e  each s u b j e c t  was t e s t e d .  
d i g i t a l i z e d  and s t o r e d  on d i s k  by a Nors ta r  Horizon microcomputer. 
A l l  d a t a  were au tomat i ca l ly  
R e s u l t s  
Table 2 l i s t s  the results of changes i n  exp i r ed  C02 
c o n c e n t r a t i o n  r e s u l t i n g  from test gases  c o n t a i n i n g  d i f f e r e n t  
FIC02's. 
c o r r e l a t i o n  c o e f f i c i e n t s  f o r  t h e  FEC02 
FIC02 l i n e s  f o r  each s u b j e c t .  
. It a l s o  l i s t s  t h e  l i n e a r  r e g r e s s i o n  equat ion  and 
FIC02 vs 
Figure 7 graphs  FIC02 
- 13 - 
vs FEC02 - FIC02 f o r  subject H . S .  (r=-0.999). This 
graph illustrates the linear relationship of the points. 
Our hypothesis is that the intercept with the abscissa of this 
easily generated line is related to the mixed venous PC02 (Table 
111) . 
Experiment 3: Comparison of third breath PcCOz prediction to - 
invasive P X 0 2  - 
Methods 
This protocol was approved by the University of Toronto and St. 
Michael's Hospital Animal Care Committee. 
anesthetized with nembutal 30 ml/kg and pancuronium bromide .04 
mg/kg. Both drugs were supplemented as necessary. The trachea was 
intubated with a cuffed $9 Portex endotracheal tube. 
Five mongrel dogs were 
One dog was 
tested during spontaneous ventilation at various depths of anesthetic 
and 4 dogs had controlled ventilation. 
a) Circuit f o r  controlled ventilation: The dogs were ventilated 
with a Bennet MA1 ventilator with a VT of 12 ml/kg. 
ventilator was attached to a circuit as illustrated in Fig. 8 and 9. 
The ventilator was found to deliver a constant tidal volume between 
The 
the rates of 6/min and 30/min. The circuit consisted of a "bag in a 
bottle" set up. 
rubber anesthesia bags inside a 5 litre bottle. 
This was initially constructed from two, three litre 
The bottle neck had 2 
.I 
openings. 
it during the inspiratory phase of the pentilator. 
was attached to the circuit by a 3-way respiratory stopcock. The test 
gas bag was attached to the circuit proximal to the dog by another 
One opening was attached to a mushroom valve which occluded 
The other opening 
respiratory stopcock. Proximal to this stopcock was the inspiratory 
limb of the circuit with a one way valve allowing gas to enter the 
circuit but not to waft back into the bag. Exhalation was 
accomplished through a port proximal to the one way valve. 
was also closed by a mushroom valve during the inspiratory phase of 
the ventilator. Thus during the control phase of the expiriment the 
- inspired volume bypassed the bottle and entered the dog (Fig. 8). For 
This port 
the test phase, the anesthesia bag was prefilled with a test gas 
containing a C02 concentration 0% - 8%. 
stopcocks were turned so that the next tidal volume from the 
ventilator entered the bottle (Fig. 9) and displaced an equal volume 
of gas from the bag into the dog. After 4 breaths the stopcocks were 
turned to the original position. The dog was again ventilated directly 
by the ventilator. 
another C02 concentration. After restoration of equilibrium, the 
test was be repeated with the new test gas. 
During exhalation the 
The bag was filled with a test gas containing 
. -  
Test gases were pre-mixed from 100% C02 and 100% O2 and 
stored in identical, unlabeled Douglas bags. Their composition was 
changed throughout the day by adding C02 or O2 to the bags. 
b) Vascular lines and monitors 
Once anesthetized, the dogs had their femoral artery cannulated. 
A silastic pulmonary catheter was passed through the external jugular 
vein. Both catheters were monitored constantly for pressure. Blood 
was sampled from the vascular catheters and analyzed for hemoglobin 
concentration, blood gases, and pH. Temperature was monitored by an 
electronic rectal temperature probe. 
constantly sampled at the mouth and analyzed by an infra-red 
. 
Tidal PC02 was 
capnograph (Beckman model LB2). 
on a Beckman type  RM dynagraph recorder .  
All va lues  were recorded cont inuously 
c)  P ro toco l  
One dog was anes the t i s ed  and t h e  t r a c h e a  in tuba ted .  Af te r  
placement of t h e  vascu la r  c a t h e t e r s ,  tes t  gases  con ta in ing  0 - 8% 
C02 were a p p l i e d  v ia  a c i r c u i t  as i l l u s t r a t e d  i n  Fig 1. 
a n e s t h e t i c  began t o  wear o f f  and t h e  dog ' s  minute  v e n t i l a t i o n  
i n c r e a s e d ,  t h e  tes t  gases  were again app l i ed .  
c 
A s  t h e  
Four dogs were v e n t i l a t e d  throughout t h e  experiment  a t  a cons t an t  
VT of 10 - 12  ml/kg. 
set and t h e  dog was allowed t o  come t o  a s t e a d y  state wi th  r e s p e c t  t o  
his mixed venous PCOz. 
The frequency s e t t i n g  on t h e  v e n t i l a t o r  was 
This was judged t o  occur  when two 
s u c c e s s i v e  P'VCO2 va lues  ( a s p i r a t e d  from the pulmonary a r te r ia l  
c a t h e t e r )  a s p i r a t e d  wi th in  5 m i n u t e s  of each o t h e r  d i f f e r e d  by less 
than  2 mm Hg. When t h i s  occurred a blood sample was .drawn from t h e  
femoral  ar tery and pulmonary a r t e r y  c a t h e t e r s  and analyzed f o r  pH, 
PC02, PO2 and Hb.  
g a s  c o n t a i n i n g  an  amount of C02  between 0 and 8Z. A f t e r  4 brea ths  
the dog aga in  was v e n t i l a t e d  d i r e c t l y  by  t h e  v e n t i l a t o r s  f o r  3 - 5 
A test cons i s t ed  of 4 breaths of a test  
minutes  while the a n e s t h e t i c  bag i n  t h e  b o t t l e  was being f i l l e d  wi th  
a n o t h e r  test  gas .  The test gases were a p p l i e d  wi thout  cons ide ra t ion  
of  t h e i r  C02 concent ra t ion  o r  t h e i r  p rev ious  o r d e r  of use.  
When a t  least 2 test gases  had been a p p l i e d  t h e  v e n t i l a t o r  
.) 
f requency was changed and t h e  dog al lowed a g a i n  t o  come t o  a new 
e q u i l i b r i u m  wi th  r e spec t  t o  h i s  PTC02. 'The above process  was 
a g a i n  r epea ted  a t  t h e  new PVC02. 
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d )  Data a n a l y s i s  
i )  Calcu la t ion  of  non invas ive  mixed venous C02 CONTENT. 
The FIC02, FECOZ and temperature  were r ead  
. 
from t h e  previous ly  c a l i b r a t e d  s t r i p  r eco rde r .  
end t i d a l  FC02 of the t h i r d  breath was taken as the 
The h i g h e s t  
FEC02. A l i n e a r  r eg res s ion  equat ion  of the 
FIC02, FEC02 - FICOZ p a i r s  was 
.computed and the l i n e  ex t r apo la t ed  t o  t h e  p o i n t  of c r o s s i n g  
t h e  abscissa. 
converted t o  p a r t i a l  p ressure .  This v a l u e  was assumed t o  be 
the PVC02. The pulmonary c a p i l l a r y  PO2 was 
c a l c u l a t e d  from the a l v e o l a r  gas  equat ion .  
and hemoglobin from the i n v a s i v e  v a l u e  were used t o  complete 
t h e  c a l c u l a t i o n  of C02. 
the BASIC t r a n s l a t i o n  of a program f o r  conver t ing  PC02 
t o  CC02 by Olszowka e t  a l .  (17). 
The invas ive  CCOz w a s  c a l c u l a t e d  i n  the same way us ing  
t h e  measured Pv’CO2, PV02, Hemoglobin, and pH. 
The f r a c t i o n  of C02  a t  the i n t e r c e p t  was 
The base excess 
These d a t a  were en te red  i n t o  
ii) 
. 
RESULTS 
Results are tabulated in Table 4. Dog 1 was breathing 
spontaneously from room air. The first test was done soon after 
induction of anesthesia. The dog was very deeply anesthetised as 
evidenced by its relative hypotension and respiratory depression. The 
respiratory rate was 4 per minute and irregular in depth and pattern. 
. 
We include this point as raw data but it does not fall within the 
criteria for inclusion in the study. During the subsequent tests the 
respirations became more regular. 
The remainder of the dogs were studied under controlled 
ventilation. 
Dogs 2 and 3 which were being ventilated by the secondary circuit 
we had constructed initially had a significant drop in their tidal 
volume when they were switched into the secondary circuit. This drop 
in tidal volume was caused by the added compliance of the 
animal-circuit system into which the ventilator delivers its constant 
tidal volume. Since the control tidal volume was greater than the test 
tidal volumes for dogs #2 and #3, the room air control value was not 
incorporated into the calculation of PVCO2. 
remaining test values should still predict the PGC02 despite this 
sudden decrease in VT. 
"bag in the box device" was constructed giving only a 10012% drop in 
VT in dogs #4 and #5. 
values in the mixed venous PC02 calculation. 
Theoretically, the 
To correct for this problem a smaller 
\ 
. We therefore incorporated these control 
Fig. 10 illustrates data obtained from dog 83.  The intercepts of 
the regression lines with the abscissa are taken as the mixed venous 
PCOz . 
In Fig. 11 we plot noninvasive vs invasive PC02. 
regression equation for this line is y = 1.37~ + 9.71 (r~0.96). 
The non invasive PC02 prediction is that of O2 saturated 
blood whereas the blood aspirated from the pulmonary artery is O 2  
desaturated. 
(ref 5). 
the same using a P X 0 2  calculated from either technique. 
1 2  we plot the C02 content as calculated by the new non invasive 
against that calculated by the invasive technique. 
equation for the line is y = 1.16~ - 6.33. 
differ significantly from 1.0 
differ significantly from 0 (p>O.l for both). 
The 
. 
This could account for the higher noninvasive values 
- Theoretically, however, the content of C02 should be 
In Fig. 
The regression 
The slope was found not to 
and the intercept was found not to 
DISCUSSION 
1. Model rationale 
a) Single compartment model for C02. 
Dubois (19) Fenn and Dejours (18) define a term "equivalent lung 
volume for C02 "ELV" which includes the air space volume which the 
breath distributes to as well as the effect of the breath on dissolved 
C02 stores such as lung tissue and blood. 
C02 entering the gas spaces during early parts of the inspiratory 
cycle come from fast space tissue buffers. 
In this concept the 
If gas is sampled early 
this would give an apparent greater volume of distribution to a breath 
of air. This difference in volume of breath distribution between 
C02 and N2 is very small but measureable (18). 
these authors have considered their data and calcualtions consistent 
Otherwise, 
with the model of the lung as having a single compartment. Fenn and 
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Dejours a l s o  showed t h a t  a s i n g l e  b r e a t h  r e s u l t  i s  n o t  a l t e r e d  by 
mixing a t t empt s  such as r a p i d  r eb rea th ing .  I n  f a c t  a l l  t h e i r  d a t a  as 
w e l l  as ou r s  are  c o n s i s t e n t  w i th  t h e  model of t h e  lung as a s i n g l e  
compartment c o n t a i n e r  w i th  ins tan taneous  mixing. . 
. b) The r o l e  of ?-A g r a d i e n t  i n  determining PGC02. 
I n  de te rmining  t h e  end t i d a l  PC02 of  a s u b j e c t  b r e a t h i n g  room 
a i r  (0% COz), t h e  model assumes t h a t  the VT of  f r e s h  a i r  
d i l u t e s  t h e  e x i s t i n g  concen t r a t ion  i n  t h e  FRC, e s t a b l i s h i n g  an  
in s t an taneous  end- insp i r a to ry  %A g r a d i e n t .  
p r o p o r t i o n a l  t o  t h i s  g r a d i e n t  d i f f u s e s  i n t o  the FRC, i n c r e a s i n g  t h e  
FRC c o n c e n t r a t i o n  t o  i t s  f i n a l  va lue  of t h e  FEC02. 
An amount of C02  
Now assume t h a t  a t es t  g a s  con ta in ing  an .amount of C02 i s  
b rea thed  f o r  3 b r e a t h s .  
r e p r e s e n t  a r i s e . t o w a r d s  a new equi l ibr ium v a l u e  of FEC02 
The r e s u l t a n t  FEC02 v a l u e s  w i l l  
( b e f o r e  a r e c i r c u l a t i o n  t ime) .  This new e q u i l i b r i u m  va lue  i s  
determined by two i n t e r a c t i n g  e f f e c t s :  one a d i l u t i o n  e f f e c t ,  t h e  
o t h e r  a d i f f u s i o n  e f f e c t .  
The tes t  g a s  serves t o  d i l u t e  t h e  g a s  i n  the FRC, a l though now 
the d i l u t i o n  e f f e c t  i s  smaller due t o  t h e  presence  of t h e  C02 
i n  t h e  i n s p i r e d  tes t  gas .  This  r e s u l t s  i n  s u c c e s s i v e l y  h i g h e r  end 
i n s p i r a t o r y  FFRC v a l u e s  analagous t o  t h e  
tes t  gas .  
I1  wash in"  e f f e c t  of  any 
Because t h e  end- insp i ra tory  FFRC v a l u e s  are h i g h e r ,  
. however, t h e  %A g r a d i e n t  i s  smaller, so t h a t  less C02 d i f f u s e s  
i n t o  t h e  lung from t h e  venous blood du r ing  t h e  f i x e d  pe r iod  of a 
b r e a t h .  It  i s  t h i s  r educ t ion  i n  g r a d i e n t  which causes  t h e  
. 
FEC02 v a l u e s  t o  level o f f  a t  a new equ i l ib r ium va lue .  
two e f f e c t s ,  taken toge the r  e s t a b l i s h  t h e  new FECOZ. 
These 
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The technique to determine FTC02, assumes that if FVC02 
were inhaled, the equilibrium FFRC would rise to F?C02 thereby 
eliminating the gradient. Thus, no C02 would diffuse into the 
lung and the expired concentration would also be equal to F X 0 2  
(i.e. the difference between inspired and expired concentrations 
be 0). 
- 
- 
Using reasoning analogous to thaw used to develop equation 
N 2 7  we state the formula for the end inspiratory C02 
concentration in the FRC 
I 
FRCEI 
F ( 4 )  
will 
for 
VT + FRC 
Where F = Fractional concentration of C02 in the FRC 
FRCEI 
at the end of inspiration 
F = Fractional concentration of C02 in the FRC 
F R C ~ ~  
end exhalation 
VT and FRC refer to the volume in milliliters of the tidal 
volume and functional residual capacity 
respectively. 
That this is a linear function of the inspired C02 
concentration can be shown by simple re-writing of the equation in the 
form 
F ~ ~ ~ E E  . FRC 
VT+FRC 
vT 
FFRCEx = [ YT + FRC ] FI + P 1 W vn m r ~ ~ ~ E E = E R b  I FRC,, = F A 
- 2 1  - 
For the sake of formula simplification, let m = VT + FRC 
F ~ ~ ~ , ,  FRC 
and b = VT + FRC 
The amount of C02 diffusing into the lung for a given time 
(AC02)  varies directly as the C02 concentration gradient 
between the mixed venous blood and the alveoli: 
where F7 = mixed venous concentration. The end tidal CO, 
L 
concentration ( F E ) ,  then must be the sum of the C02 in the 
lung at end inspiration plus the amount diffused in, divided by the 
net lung volume. 
1 
FFRcEI 
. FRC + k(G - 'T . FX +- 'FRCEE 
FE = 
VT + FRC 
from Eq. 5 and subtracting FI from 
FRCEI 
Substituting for F 
both sides to change the formulation to identify our end point: 
. FRC + k(FT - SI -b) 'T FI + 'FRCEE 
- FI FE - Fx = VT + FRC 
. FRC + k(FT - b) 
i V T  - - 1) F, + 
(7 )  
\VT + FRC 1 VT + FRC 
. 
. 
A s  was illustrated in Fig. 5, this formula represents a summation 
of two lines that we expect to cross the abscissa at FvCOZ. 
test gases whose FIC02 approach v values are given, the 
A s  
rises and the D(B-A)COZ falls. When FIC02 
PRCEI 
F 
is equal to the FTCOZ, COz gas will be added to the 
until it is equal to the FvCOz. Subsequent breaths F ~ ~ ~ , ,  
LL 
taken before recirculation should reflect the fact that FICOZ 
= F  C021TVC0z=FFRCEE COZ-FECOZ 
FRCEI 
d) 
i) Dead space (VD>. 
Expected influences on the FE'FI vs FI curve 
It is expected that the presence of dead space will not affect 
the determination of E C O z  by this technique, 
If the dead space has a long time constant and a low V/Q, one 
would expect it to have an FV C02 close to that of the 
mixed venous blood, and to contribute minimally to FE. 
If the dead space has a short time constant, and thus a high 
D 
V/Q, the F 
breathing room air. 
COz can be expected to be close to 0 when 
vD 
Considering the FECOZ of the first breath, it is 
possible that an FIC02 lower than E C O Z  would yield the 
result of FECOZ-FICOZ, thus underestimating FFCO2. 
_- 
The reason for this is that when the first breath of test gas is 
inhaled, the F 
below FICOZ while the FFRC rises slightly to a value 
higher than FICOZ. 
concentrations may combine to yield FEC02-FIC0z, 
COz rises slightly from,zero to some value . vD 
When the subject exhales, these two 
The case for FEC02 of the third breath is different 
however. By the third breath, the F C02 approaches 
FIC02, since its time constant is small and V/Q high. 
vD 
The 
is higher than FIC02 since it also contains the F~~~ 
* 
C02 that diffuses into the lung. 
therefore, must be higher than FIC02 since it is a combination 
The value of FEC02, 
of the two concentrations, FVDC02 =F I CO and 
- 
co > co . F~~~ 2 I 2 
The FE'FI line for a subject with dead space will still 
pass through FIC02=FvC02 if FEC02 of the 
third breath is considered, since then 
F C02=Fv and FFRC=F3. 
vD 
The combination of these two equal concentrations to form 
ii) Right to left shunt (Qs/QT) 
Shunted blood will alter the arterial PC02 which in turn will 
affect the PGCO2. 
areas of the lung, no systematic error in predicting the PvCOz in 
predicting the PV'CO2 is expected on this basis alone with the 
technique. The Fick technique is otherwise still valid in the 
As it is the same P?C02 that perfuses all 
presence of shunted blood. 
. iii) Cardiac output 
The difference in slope between a %first breath N2 line and 
the equilibrium C02 line is related to a "diffusion constant" 
YEq. 6 and 9) which probably reflects cardiac output influences as 
well as diffusion. For these experiments and equations we assume a 
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c o n s t a n t  c a r d i a c  output  dur ing  each test. 
PTCO2 i s  p red ic t ed  from only  one test gas  r e s u l t ,  i t  i s  assumed 
that  C.O. was cons t an t  dur ing  the  20 seconds o r  s o  of the test .  
e) 
For c l i n i c a l  purposes where 
. 
Phys io logic  e f f e c t  of brea th ing  C02 
Fowle and Campbell (21) showed the s h o r t  term capac i t ance  of the 
body f o r  C02 i s  40 ml C02/mm Hg PC02. 
FIC02 equa l  t o  the P X 0 2  f o r  3 brea ths  over  15 sec. and a 
C02 product ion  of 200 ml/min w e  can expec t  50 ml of  C02 t o  be 
r e t a i n e d  by t h e  body. 
For an 
This would g i v e  an  approximate ly  1 mm Hg rise 
i n  t i s s u e  PC02, presumeably r e f l e c t e d  i n  the r e c i r c u l a t e d  
Pv'C02. I f  a test gas  con ta ins  only a f r a c t i o n  of the FGC02, 
on ly  t h a t  f r a c t i o n  of the C02 c a n  be  expected t o  be r e t a i n e d  
g i v i n g  a n e g l i g i b l e  r i se  i n  r e c i r c u l a t e d  P8C02. 
s i t u a t i o n s  where pulmonary gas  mixing i s  poor ,  a l lowing  t h e  test t o  
The re fo re  i n  
proceed i n t o  the nex t  r e c i r c l u a t i o n  t i m e  while us ing  low FIC02 
may y i e l d  b e t t e r  r e s u l t s  on balance.  
f )  R e l a t i o n  of the technique  t o  p rev ious ly  d e s c r i b e d  techniques.  
The technique  w e  d e s c r i b e  shares  a number of  t h e o r e t i c a l  p o i n t s  
w i t h  p rev ious  techniques which we have used as a foundat ion .  DuBois 
e t  a1 ( 4 )  e s t a b l i s h e d  the concept of  an  "equiva len t  a l v e o l a r  lung 
volume" o r  EVL. 
N2 as a marker f o r  t h e  d i s t r i b u t i o n  of an  i n h a l e d  volume. 
s tudy  w e  c a l l e d  th i s  t h e  FRCEI which is the n e t  volume of 
d i s t r i b u t i o n  of a brea th .  Although th i$  may o r  may n o t  be  t h e  "FRC" 
as measured by body plethysmography o r  i n n e r t  gas  d i l u t i o n  i t  can be 
de f ined  as that  volume t h a t  a known amount of i n d i c a t o r  gas  i s  d i l u t e d  
This was la ter  used by Knowles e t  a1 (16)  us ing  
I n  this  
These authors are also credited with being the first to 
demonstrate the exponential rise of C02 in the lung during 
breatholding. This information was later used by Defares (6) and 
Collier(7) to extrapolate to PVCO2. Knowles (16) however used 
this information to demonstrate that the amount of C02 entering 
the lung per unit time was a linear function of the pulmonary capilary 
to alveolar concentration gradient. We used this information to 
predict the persistant linearity of the FE-FI vs FI curve 
for C02 . 
Despite this agreement on the basics, all of the previous 
techniques have in common attempts to equilibrate pulmonary gases to 
P?C02. 
equilibration occurs (7, 8). The other methods set conditions where 
Some methods involve finding conditions where this 
equilibration is approached physically and the final value is 
calculated mathematically (5, 6). 
Our technique is based however on stimulus and response. A 
breath of known concentration of gas is given and from the expired 
concentration of that gas all calculations are made. Each test in 
effect gives 2 points. 
FN2=.79) and the test gas. 
line through these two points is all the analysis.that is required. 
The point from room air (FIC02=0, 
An extrapolation from a straight 
SUMMARY 
We presented a technique for estimating mixed venous partial 
. pressure. 
pulmonary physiology. 
concentration of C02 other than 0 and observing the expired 
concentration. 
The technique is based on previusly accepted principles of 
The approach involves applying an inspired 
We developed the theoretical and mathematical basis 
- 26 - 
for the technique. 
Unlike previously described methods, the present technique is 
simple to perform. 
application of three or four breaths of a test gas while the patient 
continues to breath in his usual fashion. The technique is valid in 
spontaneous breathing as well as ventilated subjects. 
The calculation of P+CO2 requires only the 
- 
For the calculation of P<C02, inspired and expired FC02 
is monitored continuously. 
and the third breath of at least one test gas is noted. 
consists of plotting FEC02-FIC02 vs FIC02 for 
the control gas (FIC02=0) and at least one test gas. 
straight line is fit through these points and extrapolated to its 
End tidal C02 for FIC02 of 0 
Data analysis 
A 
intersection of the abscissa. 
We have demonstrated that this data is 
easily definable end point and correlates h 
obtained P’VCO2. 
easy to obtain, has an 
ghly with invasively 
The technique shows advantages over previously described 
techniques and as such shows promise as a basis for a new clinical 
method for measuring non invasive cardiac output. 
. 
. 
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B O  
C. 
c FI r c  
J . ' .  1 . 1  
T I 
B C 
I l lus tra t ion  of a lung model whose volume i s  "FRC" 
and the gas concentration i t  c o n t a i n s . i s  FFRC. 
The lung expands by volume VT and takes i n  
concentration FI. 
These gases are instantly mixed (by the propeller) 
and the model exhales concentration FE. 
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FISHER SYSTEM USERS MANUAL 
Startup Procedure 
. 
Refer to  Figure 6. 
1 .  Insure that gas tanks are attached and secured t ight ly.  
2. Insert FISHER SYSTEM Program Disc in to  the disc drive and 
close the drive door. 
3. Turn gases on. Second stage of the gas regulator should indicate 
approximately 5 PSI. 
4. Insure that patient mouth port i s  sealed f o r  the in i t i a l  delay . 
measurement. 
5. Turn main power switch t o  ON position. The FISHER SYSTEM 
program w i l l  load i t se l f  and auxiliary subroutines. The program w i l l  s ta r t  
the delay measurement function ( see section on MAIN MENU) and upon 
completion, w i l l  return to  the main menu. 
6. Calibrate the Andros C02 Analyser as per instructions i n  the 
calibration section. 
Calibrat ion of Andros C02  Analuser - 
The Andros C02 enalyser must be calibrated af ter  the system has been 
on f o r  a t  least 10 minutes t o  allow fo r  a stable operating temperature. To 
calibrate the meter, select option * l  from the FISHER SYSTEM MENU. The 
monitoring display w i l l  appear on the screen ( figure 2 , showing 
continuous measurements of  WCO,  - concentration and t idal  volume both 
numerical 1 y and graphical 1 y. 
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Zero Setting 
To zero the signal, use the "ZERO" knob on the front panel (see 
figure 6) and observe the numerical W C02 displsy only . Turn the knob i n  
the appropriate direction (UP indicated by "U", DOWN indicated by "D" on 
the front panel) unt i l  the meter reads some value sl ightly greater than 0% 
( for example 0.0 1 W). This slight offset w i l l  not af fect  C02 measurements 
w i th in  the specifications of  the analyser and i s  necessary f o r  the 
fol lowing reason. The Andros analyser output signal, although nominally 
0-lOV, can give B signal a t  negative voltage fo r  zeroing procedures when 
used w i th  analog systems. The FISHER SYSTEM, however, digit izes th is 
signal using an A/D converter for  computer data acquisition and analysis. 
The A/D converter responds t o  positive voltages only. Thus, a reading of  
exactly zero  on the monitoring screen may correspond t o  an of fset  
(negative) signal o f  any amount, which would af fect  any subsequent C02 
value measured. 
- Span Setting 
Once the zero has been set, test  gas * 1  i s  used t o  complete the 
two  point calibration. ( It i s  suggested that th is  procedure be carried out 
infrequently, as a sizable volume of gas i s  used.) Insure that the 
patient port i s  closed for proper calibration- Press "C" on the 
keyboard as per the instructions appearing on the monitor. The valves w i l l  
open t o  l e t  test  gas * 1  f lush past the sampling port. Al low 15-20 seconds 
fo r  the gas t o  flush out any gas that was i n  the tubing prior t o  calibration. 
Using the SPAN knob on the front panel, adjust the meter unt i l  the numeric 
display shows the concentration of test  gas " 1  (which may be read from 
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the cylinder). When th is  i s  set, press <RETURN> to turn of f  gas end return 
t o  the main menu. 
The FISHER SYSTEM MENU 
The FISHER SYSTEM i s  "menu driven". This means that any one of  i t s  
functions can be performed i n  any order desired (w i th  some restr ict ions to  
be mentioned) o r  redone as often as desired, just  by selecting the 
appropriate action from the menu. The main menu i s  a l i s t  o f  actions that 
may be performed by the system and i s  returned to  a t  the end of  each 
action. It appears on the screen os below. 
FISHER SYSTEM MENU 
1) CALIBRATE/MON ITOR 
2) COMPUTE DELAY 
3) VC02/VE/END TIDAL 
4) TEST GAS * 1  (OR TEST GAS '3) 
5 )  TEST GAS *2 (OR TEST GAS '4) 
6 )  PLOT ,- E-I 
7) CONVERT P/CCO2 AND CARDIAC OUTPUT 
8) CHANGE 6ASES TO 3 & 4 (OR 1 & 2) 
9) RESTART 
10) ARTERIAL PC02 
Some of  the l ines may be printed i n  inverse mode. These are the functions 
that have alfe8dy been performed. Any one of  these may be repeated, w i th  
the ef fect  of replacing the data from the f i r s t  measurement w i th  that of  
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the second. A description of each function w i l l  now be given. 
. 
1. CALIERATEIMONITOR 
The calibration procedure has already been described. In addition, th is  
may be used t o  monitor the patient's t idal  volume and end t idal  PC02 t o  
see i f  the patient i s  i n  a steady state. 
2. COMPUTE DELAY 
This function measures the inherent response delay o f  the Andros C02 
analyser due t o  the fact that the sample c e l l  which performs the analysis 
i s  distal  t o  the sampling port near the patient port. This i s  necessary f o r  
accurate computation of  VC02 by integration o f  the volume and C02 
waveforms. The volume measurements are transmitted t o  the computer 
electr ical ly and are thus instantaneous. This function i s  performed 
automatically a f ter  power up o f  the system, t o  insure that the delay i s  
measured. It can be remeasured by the user i f  the sampling f low rate for 
the Andros pump i s  changed. 
Before selecting th is  function, insure that  the pat ient  port i s  
closed. The system w i l l  f i l l  bag '1 w i th  test  gas * I .  The gas w i l l  then be 
flushed through the exhalation port. The system then calls a subroutine t o  
measure the delay and returns to  the main menu. WARNING: SHOULD THE 
USER SELECT THIS FUNCTION WHILE THE PATIENT IS ATTACHED 
(VENTILATED), THE PROGRAM HUST BE TERMINATED TO PREVENT 
POSSIBLE INJURY. SEE SECTION ON TERMINATION FOR THE CORRECT 
PROCEDURE !! 
-. ~- 
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3. VCO2/VF/ END TIDAL - 
This function measures minute C02 production (VC02), minute 
ventilation (VE) , and end t idal PC02. The screen monitor w i l l  appear a f t e r  
selection o f  th is function. The system w i l l  record the volume and C02 data 
fo r  5* breaths. A subroutine wi l l  be called t o  integrate the data for 
computation o f  VC02 . The C02 wave form w i l l  appear on the digit izat ion 
screen. Use the fol lowing keys t o  move the pointer t o  the desired value for 
end t idal  PC02. 
H- cursor l e f t ,  5* columns per key depression 
J- cursor l e f t ,  1 column per key depression 
L- cursor r ight,  5* columns per key depression 
K- cursor right, 1 column per key depression 
The numerical value o f  PC02 w i l l  be shown on the screen. Once the desired 
value for PC02 i s  pointed t o  by the cursor, press <I> t o  select the 
value and proceed. The digit ization process i s  repeated so that another 
end t idal  PC02 value may-be chosen ( from a dif ferent breath 1. The reason 
f o r  th is i s  that there i s  a small f luctuation i n  end t idal PCO, b over  
successive breaths. Both these values w i l l  be used i n  determining PvC02. 
*see section on changeable program parameters 
4. TEST GAS # 1 ( o r  TEST GAS *3) 
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This function administers test gas "1  (or  "3) t o  the patient and 
allows selection of the F I  and FE values by the user. Upon selection o f  th is 
function,the monitor screen w i l l  appear. The system w i l l f i l l  beg * 1  w i th  
the test  gas. Excess gas i s  used t o  f lush any gas remaining i n  the tubes 
connecting the bag t o  the patient v i a  the green "pop-off" valve located near 
the patient manifold (see figure 1). This insures a constant inspired 
concentration of gas. Once the bag i s  full, the system waits fo r  the patient 
t o  expire. 
Upon expiration, the valves a r e  opened so that the patient inspires fron 
the reservoir bag o f  test  gas. Due t o  the l imi ted size of the bag, the 
system must intermit tent ly pulse gas into the bag, while the patient i s  
exhaling. In order t o  do this, the system measures the t ime taken for  the 
patients last  exhalation and f i l l s  the bag for a fract ion o f  th is time. 
Durnig the ref i l l ing, however, the patient cannot inspire as the inspiratory 
l imb i s  occluded t o  prevent the f i l l ing gas from f lowing past the sampling 
port (see section on Changeable Parameters for  information on Frequency 
Response). Since only three breaths o f  the test gas are given , the 
maximum t idal  volume allowable should be 0 600 cc. 
A f t e r  the test gas is.administered, the valves are turned so that the 
patient i s  breathing room a i r .  The digit ization screen (see figures 3 and 4) 
w i l l  appear w i th  the C02 d8t8 from the test. The user should use the 
cursor (see cursor instructions i n  previous section) t o  select FI where the 
inspired concentration i s  constant. This concentration should be roughly 
equal t o  the concentration on the gas tank but not necessarily exactly 
equal t o  th is  number do t o  possible mixing of the test gas w i th  gas from 
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the tubing pr ior  t o  the test. Once FI i s  selected, use the cursor t o  select FE 
from the th i rd  breath. This should be the maximum value o f  the expired 
wave for  FE>FI (see figure 3) o r  the minimum value of the wave fo r  FE<FI 
(see figure 4 1. When this i s  completed, the system w i l l  return t o  the main 
menu. 
5. TEST GAS *2 (or TEST GAS *4) 
This function administers test g a P 2  (or 4) t o  the patient exactly as 
described previously w i th  test gas * l .  
6. PLOT E-I 
This function computes the regression s tat is t ics  for  the FE-FI vs F1 
l ine t o  determine PvC02 from the x-intercept. The slope, correlation 
coeff icient and PvC02 values w i l l  be displayed, followed by a graph o f  the 
regression line. Press <RETURN> t o  return t o  the main menu when finished 
viewing graph. NOTE: This function may be performed only a f te r  measuring 
end t idal PC02 gr~J administering 2 or 4 test gases. 
7. CONVERT P/CCO2 
- -  
This function calls a subroutine t o  convert PC02 t o  CC02 (by Olszowka 
et. 81. 1982). The user must enter the fol lowing patient parameters: base 
excess (if known) o r  pH, hemoglobin, PO2, and temperature. The C% 
content and O2 content of  the mixed venous blood w i l l  be printed on the 
screen. This function must not be selected unt-il the plot t ing function has 
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been selected. 
8. CHANGE GASES TO 3 & 4 
This function allows the user to add two test gases t o  the system for  a 
f i v e  point determination o f  PvC02. Gas tanks must be changed by the user 
The main menu ref lects the change. Once selected, the plot t ing function 
may not be selected unt i l  both of these gases have been administered a t  
least once. 
9. RESTART 
This function erases a l l  patient data. Calibration procedure and delay 
measurement need not be repeated a t  th is time. . 
Termination o f  Program 
Should the program at any time need to  be terminated by the user while 
performing any of the system functions (Le. not i n  the main menu mode 1, 
the fol lowing procedure should be followed for ventilated patients. Press 
<CONTROL> and <RESET> buttons on the APPLE keyboard simultaneously. 
This terminates the program and resets a l l  valves to  the o f f  position as 
indicated by the front. panel LEDs being of f .  Using the manual override 
s w i t c h e s  on t h e  front  panel ( f igure 51, turn B V 4  and BV5 to t h e  
ON posi t ion .  This insures that the venti lator volume will be delivered 
direct ly t o  the patient. 
Changeable Program Parameters 
As this version of the FISHER SYSTEM and i t s  software are prototypes 
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only, certain features of the system as well  as program parameters were 
l e f t  manipulable f o r  testing and development purposes. The following i s  a 
l i s t  of  variables which may be changed as the user sees necessary, w i th  
explanations of the parameters and the l ine numbers where they should be 
changed. 
1 .  MEMORY LOCATION 4105 - the contents o f  th is location i s  an 
indicator of  the frequency response o f  the system for  volume 
measurements i n  the following way. The routine which detects end o f  
expiration counts the t ime f o r  which the propellor i n  the f low meter does 
not turn and matches i t  against this number. The higher this number, the 
greater i s  the confidence that a true end expiration has been detected. The 
lower th is number, the faster i s  the detection and phase change f l a g  
(respiratory phase i s  indicated on the monitor screen beside the word 
EXPIRING. A 1 indicates expiration, a 0 indicates inspiration. See Figure 2.) 
The system ini t ia l izes th is value t o  60 on l ine number 1140. This may 
.. ~ 
be raised o r  lowered by the user. 
2. Eliminate Gas Pulsing - the gas pulsing t o  r e f i l l  the bag w i t h  
test  gas between breaths may be eliminated f o r  suitable t idal volumes and 
respiratory frequencies. To do this, insert as l ine 4144 the following: 
L .  
4144 GOT0 4160 
3. 81 - this variable i s  the number o f  breaths used i n  the 
measurement o f  VCO, and end tidal PC02 . The maximum number of 
breaths alloweble by the memory size i s  8 ( minimum i s  1 1 . A more 
accurate VC02 i s  measured w i th  more breaths, and this also al lows better 
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determin8tion of end t idal  PC02 since there are more t o  values t o  choose 
from. The system sets th is variable t o  5 i n i t ia l l y  on line 7025. This may 
be changed by the user. 
3. Cursor $ P I  - change 5 on lines 4485 and 4495 t o  a 
higher number ((10) for faster movement. 
Performing the Test  
To perform the test t o  determine PvC02, the fol lowing functions must 
be performed at  least once. Before start ing the user should select 
9) RESTART 
t o  insure that old patient data i s  erased. Once this i s  done, the fol lowing 
should be performed i n  any order. 
3) VC02JVElEND TIDAL 
4) TEST GAS '1 (OR TEST GAS '3) 
5) TEST GAS '2 (OR TEST GAS *4) 
Once these have been performed, repetition of any of these functions i s  
optional. In addition,--for- greater accuracy, the user may want t o  obtain 
additional data by attaching two.additiona1 gases. This may be performed 
by selecting 
8) CHANGE GASES TO 3 & 4 
attaching the gases and then performing 
4) TEST GAS '3 
5) TEST GAS '4 
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Once a l l  o f  the data points have been obtained, the user should select 
6) PLOT E-I 
t o  determine PvC02.  Should the user require CvC02 for d e t ~ t ? i n 8 t i O n  o f  
cardiac output, the user should f i r s t  select 
10) ARTERIAL PC02 
and then select 
7) CONVERT P/CCO2 AND CARDIAC OUTPUT 
For  fur ther information about each function see the section on the MAIN 
MENU. 
Trouble Shooting 
The fol lowing i s  a l i s t  of possible problems that may be encountered 
w i t h  the system and the appropriate corrective actions which should be 
taken. 
1 .  Al l  front panel l ights  on simultaneously 7 +SV supply fuse has blown. 
Turn power off. Replace (see figure 6) wi th  MDL 250W 2-5 A fuse. 
2. Patient has d i f f icu l ty  breathing test !as - patient may be trying t o  
breathe against closed valve due t o  pulsing. Patient may decrease 
respiratory rate o r  pulsing may be omitted. Frequency response may be 
adjusted (see section on Changeable Parameters). 
3. E r r o r  messages when converting PI’CCO~ - entered parameters out o f  
range . insure that a l l  requirements of a minimum test  have been 
performed including Plotting. Reselect this function. Check that enetered 
parameters are correct. 
- 
4. &pired test gas concentration not constant- check gas system for 
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leaks including ballon valves. These may be tested by opening and closing 
using the manual switches on the front panel. 
c 
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FLOW TRANSDUCER MAINTENANCE 
SC-520 
The Kozak Modular Flow Transducer SC-520 consists of the flow transducer body and a 
removable SC-521 turbine cartridge. All SC-521 cartridges are interchangeable. We 
recommend you keep a spare cartridge on hand. The transducer bodv comDrises the 
infrared oDto-electronics. and is not submersible. All the cartridges are shock Droof, 
immersible. and steriiizable. Moisture, condensed vapor, or saliva expelled by the 
patient will not affect the operation or accuracy of the flow transducer. It will provide 
long and reliable service if regularly cleaned by rinsing the cartridge in water after use, 
or cold chemical sterilization to prevent the drying-out and hardening of the saliva or 
disinfectant deposits inside the turbine cartridge. 
To remove the cartridge from the transducer bodv for inmection or cleanine, simply 
apply moderate axial pressure to the black rear part of the cartridge, and it will pop out 
easily. Secure the white front end of the cartridge with the other hand to prevent the 
cartridge from dropping on the floor while removing it. NEVER clean the cartridge by 
using a cue tip or similar cleaning probe inserted into the turbine cartridge, as this will 
damage the turbine blade and/or the pivot assembly. ALWAYS keep the transducer 
clean and use the proper disposable mouthpieces, such as the VACUMED #1026. 
Improper mouthpieces may cause air leakage, or may not otherwise work properly. To 
clean the transducer body, use a lint free dry cloth, and do not apply any pressure to the 
optical lenses inside the body. Always keep it dry. 
The accuracy of the SC-520 flow transducer is given only by the mechanical dimensions 
of the turbine and the impeller. Because the dimensions are constant and consistent, 
(precision production technology and components), calibration or recalibration is not 
needed. The operation of the transducer is strictly digital. It transmits electric pulses 
and the pulses are counted as volume increments. This is the principle of 100% drift 
free operation and long term stability. The only and essential condition for consistent 
accuracy is the proper function of the impeller, i.e., its unobstructed rotation 
capabilities. Therefore, a very simple test of flow rotation sensitivity is a reliable 
accuracy indicator. The electronic components of the flow transducer - the infrared 
emitter and the photo transistor - do not have any influence on the accuracy. Any 
malfunction of the opto-electronic system will result in loss of the electric output signal. 
SENSITIVITY TEST Take the turbine cartridge in your hand so that you are facing the 
rear black end of the cartridge. Start walking with a speed of about half to one mile per 
hour, watching the impeller rotate inside the cartridge. If the impeller does not rotate 
freely, it indicates a malfunction of the jewel bearing suspension system, caused mainly 
by the saliva deposit buildups as a result of insufficient maintenance. In such a case, 
the cartridge should be immersed in water for a few hours, and then rinsed to remove 
dissolved deposits. The most efficient rinsing method is to apply a moderate stream of 
water into the cartridge input opening (the whie end) directly from the water tap. If 
any malfunction persists, the turbine cartridge should either be sent to the factory for 
inspection, or replaced. 
(Ref E/FLOWTRAN) 
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